Cannabis and cannabinoids for the treatment of acute and chronic pain

被引：4
|
作者：
Schafer, Michael [1 ]
Tafelski, Sascha [1 ]
机构：
[1] Charite Univ Med Berlin, Klin Anasthesiol & Intensivmed, Berlin, Germany
来源：
ANAESTHESIST | 2021年 / 70卷 / 07期
关键词：
Tetrahydrocannabinol; Cannabidiol; Acute pain; Chronic pain; Cannabinoid receptors; DOUBLE-BLIND; CONTROLLED-TRIAL; CANCER-PATIENTS; ORAL DELTA-9-TETRAHYDROCANNABINOL; POSTOPERATIVE NAUSEA; NEUROPATHIC PAIN; OROMUCOSAL SPRAY; OPEN-LABEL; EFFICACY; PLACEBO;
D O I：
10.1007/s00101-021-00994-9
中图分类号：
R614 [麻醉学];
学科分类号：
100217 ;
摘要：
Since the Act on the medical use of cannabis, at which cannabis-based medicines and cannabinoids became law, there has been an exponential increase in prescriptions for the acquisition of cannabis for medical purposes. The aim of this leading article is to compile and assess the currently available relevant clinical evidence for the use of cannabis and cannabinoids for treatment of acute and chronic pain. Based on the systematic literature review "Cannabis-Potential and risks (CAPRIS)" commissioned by the German Federal Ministry of Health and the recently published recommendations of the European Pain Federation EFIC, this article aims to give an orientation aid for the decision-making process in the clinical routine.
引用
收藏
页码：551 / 562
页数：12
相关论文
共 50 条
  • [1] Cannabis and Cannabinoids for Chronic Pain
    Romero-Sandoval, E. Alfonso
    Kolano, Ashley L.
    Alvarado-Vazquez, P. Abigail
    CURRENT RHEUMATOLOGY REPORTS, 2017, 19 (11)
  • [2] Cannabis and Cannabinoids for Chronic Pain
    E. Alfonso Romero-Sandoval
    Ashley L. Kolano
    P. Abigail Alvarado-Vázquez
    Current Rheumatology Reports, 2017, 19
  • [3] Cannabinoids & cannabis: Risk-benefit analysis in chronic pain
    Vielitz, Arne
    MSKMUSKULOSKELETTALE PHYSIOTHERAPIE, 2022, 26 (03): : 124 - 124
  • [4] Medical cannabis and cannabinoids for chronic pain: Summary of a Rapid Recommendation
    Busse, Jason W.
    MacKillop, James
    JOURNAL OF MILITARY VETERAN AND FAMILY HEALTH, 2021, 7 : 118 - 122
  • [5] Medical Cannabis or Cannabinoids for Chronic Pain: BMJ Rapid Recommendation
    Hughes, Pamela R.
    Nwokocha, Jennifer
    AMERICAN FAMILY PHYSICIAN, 2022, 106 (02) : 208 - 209
  • [6] Medical cannabis or cannabinoids for chronic pain: a clinical practice guideline
    Busse, Jason W.
    Vankrunkelsven, Patrick
    Zeng, Linan
    Heen, Anja Fog
    Merglen, Arnaud
    Campbell, Fiona
    Granan, Lars-Petter
    Aertgeerts, Bert
    Buchbinder, Rachelle
    Coen, Matteo
    Juurlink, David
    Samer, Caroline
    Siemieniuk, Reed A. C.
    Kumar, Nimisha
    Cooper, Lynn
    Brown, John
    Lytvyn, Lyubov
    Zeraatkar, Dena
    Wang, Li
    Guyatt, Gordon H.
    Vandvik, Per
    Agoritsas, Thomas
    BMJ-BRITISH MEDICAL JOURNAL, 2021, 374
  • [7] Cannabinoids for the treatment of chronic neuropathic pain and spasticity
    Karst M.
    MMW - Fortschritte der Medizin, 2022, 164 (Suppl 1) : 51 - 60
  • [8] The Current Role of Cannabinoids in the Treatment of Chronic Pain
    Przeklasa-Muszynska, A.
    HEROIN ADDICTION AND RELATED CLINICAL PROBLEMS, 2018, 20 : 23 - 23
  • [9] Update on cannabis and cannabinoids for cancer pain
    Chung, Matthew
    Kim, Hee Kee
    Abdi, Salahadin
    CURRENT OPINION IN ANESTHESIOLOGY, 2020, 33 (06) : 825 - 831
  • [10] Cannabis and cannabinoids in cancer pain management
    Meng, Howard
    Dai, Tianyang
    Hanlon, John G.
    Downar, James
    Alibhai, Shabbir M. H.
    Clarke, Hance
    CURRENT OPINION IN SUPPORTIVE AND PALLIATIVE CARE, 2020, 14 (02) : 87 - 93
12345